Skip to content

Together Overcoming Diabetes - Great Plains

Culturally Grounded Diabetes Intervention With Lakota Populations in South Dakota

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06770673
Enrollment
140
Registered
2025-01-13
Start date
2025-03-11
Completion date
2028-10-01
Last updated
2026-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Brief summary

The goal of this research is to evaluate a scientifically rigorous diabetes intervention, Together Overcoming Diabetes (TOD), that has been tailored to address the unique underlying risk and protective factors and social determinants of diabetes among American Indian/Alaska Native (AI/AN) populations.

Interventions

BEHAVIORALTOD Great Plains

The adapted TOD intervention is rooted in the original TOD structure, delivery system, and home-visiting teaching schedule. Local enhancements include intervention topics and activities to address local adult caregivers' diabetes management and to promote families' modifiable risk and protective factors targeted by this proposal and informed by the Wicozani wellness concept and measurement. The TOD intervention includes targeted content taught approximately bi-weekly by family health coaches over a 16-week period.

BEHAVIORALWaitlist Standard of Care

Participants who are waitlisted to receive the TOD intervention will receive Standard of Care.

Sponsors

Johns Hopkins Bloomberg School of Public Health
Lead SponsorOTHER
The NIH Community Engagement Alliance
CollaboratorUNKNOWN
Oyate Health Center
CollaboratorUNKNOWN
National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Masking description

Independent Evaluators are masked to the study participants' randomized group status/

Intervention model description

Waitlist randomized control trial

Eligibility

Sex/Gender
ALL
Age
10 Years to No maximum
Healthy volunteers
No

Inclusion criteria

- Adult Index Participants: * 18 years and older * Self-identifies as American Indian or Alaska Native * Rapid City-based participants who reside within 1 hour transportation range of the Oyate Health Center * Verification from a health provider to confirm Type 2 Diabetes diagnosis by laboratory test. * Caregiver to a 10- to 25-year-old in their home at the time of screening. * Willing to complete all implementation and follow-up assessments. * Willing to be randomized for the intervention.

Exclusion criteria

- Adult Index Participants: * Inability to participate in full intervention or evaluation (e.g., planned move, residential treatment, etc.) * Willing to serve as 'support person' for the adult participant. * Has a circumstance that might impact successful participation based on provider judgment considering instances where diabetes control can become more difficult with advanced disease or special conditions including: pregnant, nursing, or planning to become pregnant, end-stage renal disease on dialysis, diabetes due to secondary causes such as Cushing's or Cystic Fibrosis, or any condition that may inhibit participation Inclusion Criteria - Youth Support Participants: * Between 10 years and 25 years old * Self-identifies as American Indian or Alaska Native. * Willing to serve as 'support person' for the adult participant. * Willing to complete all implementation and follow-up assessments. * Willing to be randomized for the intervention.

Design outcomes

Primary

MeasureTime frameDescription
Glycated hemoglobin (HbA1c)Baseline, 3 months, 6 months, and 12 monthsGlycated hemoglobin as measured by a point-of-care A1c test

Countries

United States

Contacts

CONTACTCourtney Claussen, PhD
cclauss1@jh.edu605-200-0043
PRINCIPAL_INVESTIGATORDonald Warne, MD, MPH

Johns Hopkins University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026